AMERICAN HEART JOURNAL, cilt.147, 2004 (SCI İndekslerine Giren Dergi)
Objectives C-reactive protein (CRP) is a prototypic marker of inflammation. The effect of tirofibon on CRP levels in patients with non-ST-elevation myocardial infarction (NSTEMI) was investigated.